HealthcareAI Research5 min reading time

Novo Nordisk and AWS bring agentic AI into drug discovery

AI News (TechForge)
Read full post
Novo Nordisk is partnering with AWS to integrate AI agents into drug discovery, establishing a co-innovation hub in London to accelerate research from target identification to clinical dosing. The collaboration leverages AWS cloud and AI tools, including generative AI, to enhance workflows and reduce documentation time significantly.

More in Healthcare

Google DeepMind Releases AlphaGenome Atlas Mapping 9 Billion Human DNA

Forbes
Healthcare3 min read

Mark Wahlberg is coming to TechCrunch Disrupt 2026, and he wants to talk about your work, not his

TechCrunch

UK Is Urged to Overhaul Regulation of AI-Medical Devices

Covered by 2 sources